Advertisement
Grab your lab coat. Let's get started
Welcome!
Welcome!
Create an account below to get 6 C&EN articles per month, receive newsletters and more - all free.
It seems this is your first time logging in online. Please enter the following information to continue.
As an ACS member you automatically get access to this site. All we need is few more details to create your reading experience.
Not you? Sign in with a different account.
Not you? Sign in with a different account.
ERROR 1
ERROR 1
ERROR 2
ERROR 2
ERROR 2
ERROR 2
ERROR 2
Password and Confirm password must match.
If you have an ACS member number, please enter it here so we can link this account to your membership. (optional)
ERROR 2
ACS values your privacy. By submitting your information, you are gaining access to C&EN and subscribing to our weekly newsletter. We use the information you provide to make your reading experience better, and we will never sell your data to third party members.
Business
Genzyme Diagnostics Go To Japan’s Sekisui
by Michael McCoy
November 22, 2010
| A version of this story appeared in
Volume 88, Issue 47
Genzyme has agreed to sell its diagnostics business to Japan’s Sekisui Chemical for $265 million. With 2009 sales of $167 million, the business provides raw materials, enzymes, chemistry reagents, and rapid tests used to make diagnostics for various diseases. It’s one of three businesses that Genzyme put up for sale in May. Three months later, Genzyme turned down a takeover offer by Sanofi-Aventis. Sekisui has supplied diagnostic raw materials to Genzyme since 1995.
You might also like...
The power is now in your (nitrile gloved) hands
Sign up for a free account to get more articles. Or choose the ACS option that’s right for you.
Already have an ACS ID? Log in
Join the conversation
Contact the reporter
Submit a Letter to the Editor for publication
Engage with us on Twitter